Deficiencia de vitamina D: ¿Factor de riesgo de síndrome metabólico?:Vitamina D y síndrome metabólico

Abstract

Vitamin D has an essential role in calcium metabolism and bone health. Vitamin D3 or cholecalciferol is synthesized from 7-dehydrocholesterol or provitamin D3, by sunlight ultraviolet radiation to the skin. 7-dehydrocholesterol is subsequently hydroxylated in the liver and then in the kidney to produce 1,25-(OH)2D3, the active metabolite that binds to specific receptors (VDR) in target tissues, mainly bone and intestine. Other tissues, such as the immune and cardiovascular system, have also VDR. Vitamin D deficiency can induce rickets in children and osteomalacia and osteoporosis in adults. A possible inverse association between vitamin D levels and the prevalence of metabolic syndrome has been proposed. Vitamin D deficiency increases the risk of type 1 diabetes, insulin resistance, and hypertension, key components of this syndrome. However, other studies have not confirmed this association. Further clinical and experimental studies are needed to ascertain the role of vitamin D in metabolic syndrome.

Publication DOI: https://doi.org/10.4067/S0034-98872010001100017
Divisions: College of Health & Life Sciences > Aston Medical School
College of Health & Life Sciences > Aston Medical School > Translational Medicine Research Group (TMRG)
Additional Information: Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons
Last Modified: 05 Dec 2024 08:17
Date Deposited: 08 Oct 2019 12:11
PURE Output Type: Article
Published Date: 2010
Authors: Sanchez Aranguren, Lissette (ORCID Profile 0000-0002-4663-5752)

Export / Share Citation


Statistics

Additional statistics for this record